Enzon Pharmaceuticals, Inc. announced earnings results for the first quarter ended March 31, 2020. For the first quarter, the company announced total revenue was USD 2,000 compared to negative total revenue of USD 51,000 a year ago. Operating loss was USD 240,000 compared to USD 369,000 a year ago. Net loss was USD 242,000 compared to USD 371,000 a year ago. Basic loss per share from continuing operations was USD 0.01 compared to USD 0.01 a year ago.